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Abstract
Background: to verify the association of seminal parameter (SP) and 
seminal ferritin (SF) levels in patients undergoing chronic hemodialysis 
(CH), admitting possible antioxidative activity of SF. 
Methods: This was a case-control study in group of 60 men (case) 
in CH with more than 6 months and group of healthy men (control), 
aged 18-60 years, without clinical or laboratory signs of infection/
inflammation. Patients underwent semen analysis, fertility index (FI) 
calculation, measurement of SF and hormonal profile (follicle-stimula-
ting hormone, luteinizing hormone, total testosterone, and prolactin 
levels). 
Results: There were significant differences between cases and con-
trol (Table 1) in SP (p = 0.000), sex hormone (p = 0.000) and FI [0.85 
(0.57) vs 5.54 (1.3), p=0.000]. There was no difference between cases 
and control (Table 1) in SF levels (226.45 ± 51.03 vs 241.52 ± 30.52, 
p = 0.137) and age (49.47 ±5.56 vs 47.90 ± 6.22, p=0.229). There 
was no correlation (Table 2) between SF and FI (r = 0.049, p = 0.711) 
and SP (p> 0.05). 
Conclusion: The results suggest that SF is not associated with 
changes in seminal parameters in patients undergoing chronic he-
modialysis, and is not useful singly for initial evaluation of seminal 
parameters.
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Introduction
Subfertility and infertility in patients with chronic 
kidney disease (CKD)/hemodialysis (HD) is frequently 
encountered, presenting as a reduction in one or 
more seminal parameters (SP) (concentration, mo-
tility, morphology, and vitality of spermatozoa) [1]. 
Semen quality is the result of the synchronic interac-
tion of several factors involved in the complex sper-
matogenesis process, including genetic, hormonal, 
immunological, oxidative, and inflammatory factors 
[2]. DRC/HD is characterized by an increase in oxida-
tive stress (OS) and inflammation [3]. Is accepted the 
association between OS and increased synthesis of 
proinflammatory cytokines such as interleukin-6 (IL-
6), tumor necrosis factor α (TNF-α) induced by the 
activation of nuclear factors such as kappa nuclear 
factor B (FN-κB) [3]. Or activator protein-1 (PA-1) [3] 
and consequent elevation of acute phase reaction 
proteins such as fibrinogen and C-reactive protein 
(CRP), suggesting that CKD is a low-grade chronic 
inflammatory state [4]OS is one of the main factors 
responsible for subfertility and infertility in humans 
[5]. Evaluation of seminal SO is usually performed 
by measuring the total antioxidative capacity of the 
semen (evaluating the enzymatic and non-enzyma-
tic systems) or individualized lipid peroxidation by-
products, such as malonaldehyde (MDA), protein 
(carbonyls), nucleic acids (oxidized nitrogen bases), 
and carbohydrates (glycosylation products) [6]. Few 
studies have separately evaluated seminal OS via the 
non-enzymatic antioxidant system. 
The different isoforms of ferritins, in addition to 
the intracellular iron ion storage function, they are 
admitted antioxidant function by controlling the 
iron ions in the intracellular environment by chela-
tion mechanism [7].
Objective
Considering the low quality of semen observed 
frequently in CKD/HD patients, it was decided to 
verify the possible association between seminal fe-
rritin (SF) levels and seminal parameters in patients 
on chronic hemodialysis, hypothesizing possible SF 
antioxidative activity.
Methods
Recruitment, inclusion and exclusion
Prospective study of prevalence in the Hemodialysis 
Sector of the University Hospital of the University 
of Brasília, between July 2016 and December 2016, 
after approval by the Research Ethics Committee of 
the Faculty of Health Sciences of the University of 
Brasília under number 53172316.9.0000.0030. In-
clusion criteria were: age between 18 to 60 years, 
has been in HD for more than 6 months (cases) and 
absence of acute or chronic liver disease. Exclusion 
criteria were the presence of hemochromatosis or 
diseases of iron metabolism. Were not included in 
the study patients with hypogonadism and clinical 
conditions that could alter SF levels such as re-
cent history of genitourinary tract infection, clinical 
signs of acute or chronic infection/inflammation, 
positive serology for hepatitis B, C and HIV, vascu-
lar access infection, leukocytosis, fever, hypoprotei-
nemia. Sample consisting of 60 men (case) in high 
flow HD by vascular fistula access, 3x week with 
duration of 4 hours/HD session and 30 healthy 
men (control) from the health promotion outpa-
tient clinic of the same hospital with normal renal 
function, this is, above 90mls/min/1.73m2 and a 
normal CRP value (≤1 mg/L) considered for a low 
cardiovascular risk [8].
Routine collection of blood and semen
The blood sample for analysis was collected from 
the arteriovenous fistula immediately before the 
first weekly hemodialysis session in the case group 
and on a previously scheduled day for the control 
group, always between 8:00 and 10:00 a.m. in the 
clinical laboratory of the same hospital. Were mea-
sured SF, follicle-stimulating hormone (FSH); luteini-
zing hormone (LH); prolactin (PRL) and total testos-
terone (TT). On the same day of blood collection, 
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the semen was collected by voluntary masturbation 
in an appropriate environment at 37° C to perform 
spermogram by manual method according to the 
guidelines of the WHO laboratory manual for the 
examination and processing of human semen 5th 
ed [9] and seminal plasma preparation, centrifuging 
at 3500 × g for 20 min after 30 minutes lique-
faction. The supernatant was collected into a new 
tube and held at -20° C for the measurement SF. 
SF and sex hormones (SH) were measured by enzy-
me immuno-chemiluminescence using the Immulite 
2000/Siemens automatic analyzer. Specific kits were 
used for quantification, as well as calibrators and 
controls recommended by the manufacturer.
Fertility Index (FI)
IF was calculated according to Harvey [10] as fo-
llows: FI = sperm concentration (x 106/ml) x sperm 
motility x percentage of spermatozoa with normal 
morphology.
Statistical analysis
After the normal distribution curve of the sample 
was verified by normality tests, for differences bet-
ween two independent quantitative variables was 
used t-test and Pearson correlation analysis. Statisti-
cal significance was set at p <0.05 to reject the null 
hypothesis. Used SPSS® for Windows, version 20.0
Results
There were significant differences between cases 
and control (Table 1) in SP (p = 0.000), sex hor-
mone (p = 0.000) and FI [0.85 (0.57) vs 5.54 (1.3), 
p=0.000]. There was no difference between cases 
and control (Table 1) in SF levels (226.45 ± 51.03 vs 
241.52 ± 30.52, p = 0.137) and age (49.47 ± 5.56 
vs 47.90 ± 6.22, p=0.229).There was no correlation 
(Table 2) between SF and FI (r = 0.049, p = 0.711) 
and SP (p> 0.05). 
Table 1.  Comparative evaluation of age, semen and 
hormone parameters, index and ferritin se-
minal levels among groups case and con-
trol (x ± sd).
Observational Case Control pa
-valorsparameters n (60) n (30)
Age (y) 49.47 ± 5.56 47.90 ± 6.22 0.229
Semen volume 
(ml)
01.33 ± 00.36 02.77 ± 0.44 0.000
Total motility 
(PR + NP, %)
34.00 ± 06.24 71.31 ± 7.86 0.000
Sperm 
vitability (%)
47.49 ± 07.31 64.41 ± 2.89 0.000
Sperm density 
(x 106/ml)
14.95 ± 06.18 50.21 ± 8.57 0.000
Morphology 
sperm (%)
25.40 ± 07.87 59.76 ± 10.58 0.000
FSH (mIU/ml) 06.30 ± 01.21 03.40 ± 00.48 0.000
LH (mIU/ml) 15.91 ± 02.62 02.84 ± 00.54 0.000
Testosterone 
(ng/dl)
411.03 ± 58.88 510.60 ± 92.56 0.000
Prolactin 
(ng/ml)
16.38 ± 02.92 05.86 ± 01.93 0.000
Fertility index 0. 85(0.57) 5.54(1.3) 0.000
Ferritin seminal 
(ng/ml)
226.45 ± 51.03 241.52 ± 30.52 0.137
PR: Progressive motility; NP: non-progressive motility; 
FSH: follicle-stimulating hormone; LH: luteinizing hormone; 
a: t tests
Table 2.  Correlational evaluation Pearson` between 
seminal ferritin and seminal parameters in 
group of case (p < 0.05 significative).
Observational Case (n=60)
Parameters r p
Seminal ferritin
Fertility index 0.049 0.711
Sperm motility -0.005 0.971
Sperm viability -0.088 0.504
Sperm density -0.007 0.960
Sperm morphology 0.003 0.980
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Discussion
The present study intends to add knowledge in the 
understanding of the changes observed in the SP 
of patients with CKD, especially in HD, studying 
the possible association of SF levels with these al-
terations, considering possible antioxidative activity 
attributed to SF. This activity is due to its physio-
logical function of regulating intracellular iron ion 
concentration, avoiding excessive formation of Fe++ 
by the reduction of free iron (Fe+++) by anion (O2
-), 
not favoring the biochemical reactions of Fenton 
and Haber-Weiss generating the hydroxyl radical (• 
OH), most reactive of ROS responsible for peroxi-
dation of lipid, protein, glycides and fragmentation 
of DNA [11].
SF is an isoform of the different ferritins found in 
humans tissues, abundant in human seminal plas-
ma; it is primarily produced and secreted (80%) by 
Sertoli cells [12] sensitive to systemic or local inflam-
matory changes [13].
On the other hand, Spermatogenesis is an iron-
dependent process, because developing male germ 
cells undergo many mitotic divisions and require iron 
for DNA synthesis and cell growth, in particular for 
mitochondriogenesis. In addition, maturing sperma-
tids and spermatozoa are extremely vulnerable to 
oxidative stress, implying a need for a well-balanced 
iron homeostasis in the seminiferous tubule [14]. 
This may partially justify the high concentrations of 
this protein in seminal plasma.
The similar age between the groups studied (p 
> 0.05) ensures greater reliability in the interpreta-
tion of the results and in the comparative statistical 
analysis of the impact of age on outcome variable 
[15].
Sex hormones (SH)
The most commonly observed male sex hormones 
(SH) profile in patients with CKD/HD is elevated 
serum levels of follicle stimulating hormone, lutei-
nizing hormone, and prolactin and decreased serum 
TT levels, in response to the inhibitory action in one 
or more sites of the hypothalamic-pituitary-gonadal 
(HPG) axis promoted by factors such as uremia, 
OS, and pro-inflammatory cytokines generated 
by CKD/HD [16]. The SH profile (Table 1) between 
case and control follows the previously described 
pattern, with significant differences between them 
(p=0.000). These results are corroborated by pre-
vious reports [1, 17]. The absence of clinical hypo-
gonadism in the sample, in principle, removes the 
interference of the hormonal factor on SP, FI, and 
SF levels.
Fertility Index (FI) and Seminal Parameters 
(SP)
The FI was significantly lower in the case group than 
in the control group (p = 0.000). Our results are in 
agreement with results obtained by other authors 
in similar studies. Xu et al [18] in the study of the 
semen quality in (40) uremic patients, (40) trans-
planted renal patients, and (40) healthy and fertile 
men, found higher IF for healthy patients in relation 
to transplanted groups A and B and uremic, respec-
tively, 13.02 (14.26); 5.53 (8.30); 9.27 (22.49) and 
0.23 (0.76). Xu et al. [19], evaluating the effect of 
uremia on semen quality and reproductive function 
in 53 terminal uremic patients, comparing them 
with controls of 46 fertile and 46 infertile men. They 
found that the motility, survival rate, density and 
morphology of the remaining 46 uremic patients 
were significantly lower than controls. The uremic 
patients presented IF 0.68 (2.08) significantly lower 
than the fertile 7.7 (13.51) and infertile 4.13 (5.77). 
(Table 1)
Although the antioxidative activity of ferritin is 
admitted in thesis, its evidence in clinical practice is 
questioned, considering the limited number of stu-
dies about the theme. Kwenang et al. [20] analyzed 
levels of iron, copper, and ferritin in seminal plasma 
from young healthy students (n=30) and infertility 
(n=30) with severe teratospermia, and no significant 
differences were found between them. However, 
Ferreira et at. [21], analyzing the seminal plasma 
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oxidative/antioxidative capacity of 69 men with sus-
pected infertility and their association with iron and 
SF levels, showed a positive correlation between SF 
and total antioxidant capacity (p = 0.005) and a 
negative correlation with OS index (p = 0.02, r = 
-0.329). They concluded that the measurement of 
SF can be useful in the evaluation of seminal oxi-
dative/antioxidative status in studies of fertility and 
seminal oxidative stress.
The complex systemic inflammation and oxidative 
stress affecting 40-60% of patients with CKD in HD 
[22] is a clinical condition that can alter SF levels. 
It is accepted that SI is associated with increased 
synthesis and secretion of intratesticular proinflam-
matory cytokines by stimulation of macrophages, 
Sertoli cells, and Leydig cells with nonpermanent al-
terations in SP (subfertility and infertility), evidenced 
in animal models and human studies [23]. 
Study experimental in rodents demonstrated 
that Il-6 secreted by the Sertoli cell stimulates the 
production of intratesticular SF [24]. In the animal 
model, the induction of systemic inflammation by 
lipopolysaccharide injection (LPS) promoted unsus-
tainable elevations in proinflammatory cytokines 
(TNFα, interferon gamma [IFNγ], IL-6, IL-12, IL-17, 
and IL-23). Decreases in SP and elevations of a li-
pid peroxidation marker (MDA) lasted up to 30 
days after the inflammatory induction, with values 
returning to baseline values later [25]. In humans, 
Qian et al [26] verified the relationship between 
different cytokines in the semen samples of 57 
patients with infertility, identifying a decrease in 
SP and a significant difference in IL-23 levels of 
semen in the normal (5.87 pg/mL) and abnormal 
(11.14 pg/mL) groups (p < 0.001), with positive co-
rrelations between IL-6, IL-8, and TNF-α. Kokabet 
et al [27] evaluated whether IL-6 and IL-8 concen-
trations and numbers of seminal leukocytes were 
related to chlamydial infection in a population of 
255 men with infertility. Significantly, increased le-
vels of IL-8, but not IL-6, were found in patients 
with trachomatis infection when compared with 
uninfected patients, and there was a correlation 
between trachomatis infection and lower progres-
sive motile sperm, as well as an increase in seminal 
leukocytes.
Silva et. al [28] studying effect of systemic in-
flammation on level of ferritin seminal in chronic 
renal male patient undergoing hemodialysis, using 
similar methodology, examined a sample of 60 
patients on HD and did not find differences or 
correlations of SF levels among patients with in-
flammation, without inflammation, and controls 
(p > 0.05). Wan et al. [29] investigated the asso-
ciation between chlamydia trachomatis infection 
and the contents of seminal plasma ferritin, β-2-
microglobulin, and total protein in seminal plas-
ma of 30 fertile men (normal group) and 62 men 
with infertility infected by chlamydia trachomatis. 
They found higher concentrations of SF level in 
the infected group compared to healthy controls. 
It is plausible to hypothesize that disagreement is 
apparent for the behavior of SF levels of inflam-
mation in the two previous studies. Silva et. al [28] 
evaluated patients with chronic systemic inflam-
mation with consolidated adaptive process; Wan 
et al. [29]evaluated patients with acute local or 
subacute infection. With resolution of an acute in-
fectious stimulus, proinflammatory cytokines and 
SF levels tend to normalize [30]. (Table 2)
Considering little known in the mechanism that 
causes of the low quality of semen and without 
correlation with SF levels in the group of patients 
studied, it is plausible to hypothesize that other fac-
tors are associated with the DRC/HD condition, be-
sides the uremic factor, contribute to decrease the 
seminal quality as inflammation systemic (IS), OS or 
both by diverse mechanisms [2].
The similar level of SF in the case and control 
group identified in the present study may be partia-
lly justified by local immunosuppressive milieu and 
systemic immune tolerance are involved in maintai-
ning testicular immune privilege status in response 
to uremic, IS, OS, isolated or associated factors. The 
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testicular immune privilege is a complex mechanism 
developed in the testicular compartment to main-
tain the balance local of pro/anti-inflammatory cyto-
kine levels [31], involved in regulation the synthesis 
of SF [32] and intracellular iron ion level via the ion 
regulatory protein (IRP) [33]. Mechanisms of functio-
nal interactions between germ cells and Sertoli cells; 
Sertoli cells and Leydig cells, known as autocrine/
paracrine regulation and hematopoietic barrier, are 
also part of the mechanism of testicular immune 
privilege protecting germ cells from effect inflam-
matory/oxidative/ionic toxicity [34]. The breakdown 
of homeostasis of one of these mechanisms may 
explain in part the genesis of changes in the semi-
nal parameters of these patients. The present study 
presents the following limitations: absence of com-
plementary analysis of seminal of OS and reduced 
sample.
Conclusion
The results suggest that SF levels are not associa-
ted with changes of seminal parameters in patients 
undergoing chronic hemodialysis and is not useful 
singly for initial evaluation of seminal parameters.
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